Regenxbio (RGNX) Asset Utilization Ratio (2016 - 2025)
Regenxbio (RGNX) has 11 years of Asset Utilization Ratio data on record, last reported at 0.35 in Q4 2025.
- For Q4 2025, Asset Utilization Ratio rose 105.98% year-over-year to 0.35; the TTM value through Dec 2025 reached 0.35, up 105.98%, while the annual FY2025 figure was 0.37, 131.46% up from the prior year.
- Asset Utilization Ratio reached 0.35 in Q4 2025 per RGNX's latest filing, up from 0.29 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.52 in Q3 2022 and bottomed at 0.11 in Q3 2021.
- Average Asset Utilization Ratio over 5 years is 0.25, with a median of 0.18 recorded in 2024.
- The widest YoY moves for Asset Utilization Ratio: up 359.18% in 2022, down 73.28% in 2022.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.49 in 2021, then tumbled by 73.28% to 0.13 in 2022, then grew by 13.81% to 0.15 in 2023, then increased by 13.21% to 0.17 in 2024, then surged by 105.98% to 0.35 in 2025.
- Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.35 in Q4 2025, 0.29 in Q3 2025, and 0.29 in Q2 2025.